AKT1 and cancer: Studies on esophageal squamous cell carcinoma and hepatocellular carcinoma have shown that high expression of lncRNA-CASC9 activates the PI3K/AKT signaling pathway, promoting the proliferation, invasion, and metastasis of cancer cells (204, 205).